molecules 2

Modelis Takes The Risk Out Of Drug Discovery

We aim at providing a state-of-the-art solution to develop therapies in a rapid and economical manner. Modelis is revolutionizing the outdated target-based drug-discovery pipeline by offering an unbiased approach using multiple model organisms. Our innovative and unprejudiced approach maximizes discovery of new drugs and repurposes known molecules rare diseases.

WHAT DOES MODELIS DO DIFFERENTLY

Taking Advantage Of Simple Models

However far from a worm or a fish we may feel and look, 80% of the genes causing human diseases are evolutionarily conserved in these animals. For example, the molecular basis of cancer or the main neuronal networks are present in these species and function like ours. Thus, these simple models are suitable for investigating a wide range of human disorders. Thanks to their small size, worms and fish are central in Modelis’ drive aiming at offering a fast and cost-friendly approach. 

Broadening The Spotlight Of Drug Discovery

While the classical approach is focusing all efforts on a specific class of molecules, possibly missing the cure, Modelis’s drug discovery pipeling considers a broad class of molecules to ensure a thorough investigation for successful drug discovery.

Assaying The Global Health For A Fast And Meaningful Readout

Modelis’ approach relies on the identification of molecules reverting sick behaviours (or phenotypes) in living organisms rather than on a tiny molecular aspect of the disease. Our approach seeks to cure the entire animal along with all associated molecular aspects of the disease. 

HOW WE DO IT

From Thousands Of Molecules To The One

From worms to humans, Modelis takes advantage of multiple, complementary animal models to encapsulate the complexity of the diseases in order to maximize rapid and cost-efficient drug discovery.

WHY WORK WITH US

flexible 2

FLEXIBLE

Modelis considers each drug discovery venture as unique and will design a specific experimental pipeline fitting your project.

unbiased

UNBIASED

Modelis’ strategy does not rely on defunct approaches. Our high-throughput pipeline allows us to test thousands of compounds and to consider unexpected candidate drugs.

innovation

Innovative

Modelis’ approach is novel, taking advantage of multiple simple models in which complex diseases can be modeled in a standardised and quantifiable fashion.

success

Successful

Modelis’ strategy has been successfully tested in the past and brought a therapeutic solution whereas the classical approach failed.

HOW CAN WE HELP YOU

See How Modelis Can Be Your Partner For All Your Drug Discovery Needs

I am a Patient, Family, or Patient Advocacy Group

I am a Pharmaceutical Company, Biotech, or CRO